PubMed HealthSearch

Biomedical subjects

A Manitius

Publications and source records attributed to A Manitius.

At least 19 recordsLinked to original sources

[Effects of alpha and beta receptor blockaders on urinary excretion of sodium and potassium in healthy rats and in those with chronic renal failure].

The aim the study was to investigate the effects of both alpha and beta adrenergic blockade on sodium and potassium excretion in rats with chronic renal failure. The chronic renal failure was induced by surgical ablation of 75% renal mass. Controls were shame operated rats. All experiments were performed under sodium pentobarbitone anesthesia. Blood pressure was measured intraarterially and glomerular filtration rate was estimated as inulin clearance. Phentolamine (4 micrograms/kg/min)--Group I; or propranolol (4 micrograms/kg/min)--Group II were infused i.v. to controls and chronic failure rats. alpha-receptor blockade with phentolamine lowered GFR and blood pressure to the same extent in controls and rats with chronic renal failure. alpha-blockade caused increased fractional sodium excretion only in controls while urinary excretion of sodium and potassium fell in rats with chronic renal failure. The beta-blockade with propranolol (4 micrograms/kg/min)--Group II did not affect both blood pressure and GFR either in controls nor in rats with chronic renal failure. However propranolol infusion increased sodium and potassium excretion in controls but not in rats with chronic renal failure. Our study showed the divergence in the role of adrenergic receptors in regulation of urinary electrolytes excretion between controls and rats with chronic renal failure.

Animals

[Subcutaneous administration of recombinant human erythropoietin (R-EPO) in the treatment of anemia in predialysis patients with chronic renal failure].

10 anemic (HB less than 9.0 g/dl) predialysis patients with chronic renal failure were treated for three months with s.c. administration of r-Epo. Blood morphological parameters were estimated using hematological autoanalyser Technicon H1. An increase of the mean hemoglobin (Hb) level from 8.39 to 10.57 g/dl was observed. In 8 patients Hb concentration after 3 months therapy ranged from 9.4 to 12.7 g/dl, but in the remaining two of them Hb was lower than 9.0 g/dl. Appearance of a high percentage of hypochromic erythrocytes is probably the most characteristic response to r-Epo treatment. This phenomenon was caused by iron deficiency. A significant increase of serum creatinine and BUN levels were observed in treated patients, without the concomitant decrease of endogenous creatinine clearance. No clinical symptoms suggesting deterioration of the renal function were observed. Subcutaneous therapy with r-Epo appeared an effective and convenient method of treatment of anemia in predialysis patients.

Adult

[Evaluation of erythropoiesis under the influence of recombinant human erythropoietin (R-EPO) in dialyzed patients].

5 deeply anemic (Hb less than 8 g/dl, Ht less than 25%) dialyzed patients with chronic renal failure were treated during four months with r-Epo. Blood cells morphological parameters were estimated using hematological autoanalyser Technicon H1. Satisfactory increase of the Hb levels and RBC counts were observed in 4 patients, in one the improvement was insignificant. We observed three types of response to r-Epo treatment: 1) macrocytic type, 2) hypochromic type, and 3) non-hypochromic type, without lasting macrocytosis. Our results suggest that type of erythropoiesis depends on other active biological substances (iron, folic acid, vit. B12) necessary for correcting erythropoiesis. r-Epo administration appeared to be a safe and effective method of anaemia treatment in dialyzed patients. Its administration eliminated blood transfusion for six months.

Adult